Rap1−/−-BM-MSCs lowers NF-κB sensitivity to stress-induced pro-inflammatory cytokine secretion and apoptosis to improve MSC-based therapeutic efficacy in myocardial infarction compared with BM-MSCs. Here, NFKB1 is linked to myocardial infarction.